Omri Amirav Drory
InvestorGeneral Partner at NFX
San Francisco Bay Area
Writes $500K – $5M checks · typically $3M
FoundedImmuneBridgeLa Jolla LabsPepper BioResistanceBio · YCTalus Bio · YCTwoStep Therapeutics
About
Omri Amirav-Drory is a founder-operator with TechBio lifecycle experience—founding Genome Compiler (acquired by Twist Bioscience), serving as Twist VP of Corporate Development and Innovation and acting as CEO during incubation.
Invests in
AI & Machine LearningBiotechCrypto & Web3FintechMarketplaces
Experience
- EarthTraq CorporationBoard Membercurrent2026 — present
- PortalBoard Membercurrent2026 — present
- Cyclana BioBoard Membercurrent2025 — present
- ImmuneBridgeBoard Membercurrent2025 — present
- Powerhouse BiologyBoard Membercurrent2025 — present
- Permanence BioBoard Membercurrent2025 — present
- Radar TherapeuticsBoard Membercurrent2024 — presentSan Francisco Bay Area
- TwoStep TherapeuticsBoard Membercurrent2024 — presentSan Francisco Bay Area
- ZipBioBoard Membercurrent2023 — present
- CentivaxBoard Membercurrent2022 — present
- Renewal BioFounder & chairman of the boardcurrent2022 — presentRehovot, Center District, Israel
- PumpkinseedBoard Membercurrent2022 — present
- Talus BioBoard Membercurrent2021 — present
- Mana.bioBoard Membercurrent2021 — present
- Nanocarry TherapeuticsBoard Membercurrent2021 — present
- NFXGeneral Partnercurrent2020 — present
- Eleven TherapeuticsBoard Membercurrent2020 — present
- EdiTy TherapeuticsBoard Membercurrent2020 — present
- ImmunaiAdvisorcurrent2020 — present
- Light Bio, Inc.Board Membercurrent2020 — present
Education
- Stanford UniversityPostdoctoral, Biochemistry and Molecular Biology2007 — 2011
- Tel Aviv UniversityDoctor of Philosophy (Ph.D.), Biochemistry2003 — 2007
- Tel Aviv UniversityBachelor of Science - BS, Biochemistry and Molecular Biology2001 — 2003
Skills & more
+12 more
DNATechnology TransferPersonalized MedicineBiomedical EngineeringPCRCancerScientific WritingProtein ExpressionBiophysicsProteomicsDrug DiscoveryIn VitroFrom Omri's professional profile.
Same school
Also attended Stanford University1,726
+ 1,720 more
Also attended Tel Aviv University335
+ 329 more
Shared employers
Also worked at Portal1
Also worked at Radar Therapeutics1
Also worked at TwoStep Therapeutics1
Deals · 5
TwoStep TherapeuticsBoard seat
via NFX · filed Jan 2026 · $62.2M raise
ImmuneBridgeBoard seat
via NFX · filed Apr 2025 · $7.1M raise
ResistanceBioBoard seat
via NFX · filed Jan 2024 · $12.8M raise
La Jolla LabsBoard seat
via NFX · filed Oct 2021 · $3.5M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at NFX
Network4
Investors connected to Omri in public investor directories — a warm-intro map.
























